Phytohealth Corp (Taiwan) Performance
| 4108 Stock | TWD 16.00 0.05 0.31% |
Phytohealth Corp has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.32, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Phytohealth Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding Phytohealth Corp is expected to be smaller as well. Phytohealth Corp right now holds a risk of 1.32%. Please check Phytohealth Corp potential upside, kurtosis, and the relationship between the value at risk and skewness , to decide if Phytohealth Corp will be following its historical price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Phytohealth Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Phytohealth Corp is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 61.2 M | |
| Total Cashflows From Investing Activities | -581.1 M |
Phytohealth |
Phytohealth Corp Relative Risk vs. Return Landscape
If you would invest 1,585 in Phytohealth Corp on December 23, 2024 and sell it today you would earn a total of 15.00 from holding Phytohealth Corp or generate 0.95% return on investment over 90 days. Phytohealth Corp is generating 0.025% of daily returns and assumes 1.3163% volatility on return distribution over the 90 days horizon. Simply put, 11% of stocks are less volatile than Phytohealth, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Phytohealth Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phytohealth Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Phytohealth Corp, and traders can use it to determine the average amount a Phytohealth Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.019
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4108 |
Estimated Market Risk
| 1.32 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Phytohealth Corp is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phytohealth Corp by adding it to a well-diversified portfolio.
Phytohealth Corp Fundamentals Growth
Phytohealth Stock prices reflect investors' perceptions of the future prospects and financial health of Phytohealth Corp, and Phytohealth Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Phytohealth Stock performance.
| Return On Equity | -0.0431 | |||
| Return On Asset | -0.0366 | |||
| Profit Margin | (0.53) % | |||
| Operating Margin | (1.00) % | |||
| Current Valuation | 3.1 B | |||
| Shares Outstanding | 198.62 M | |||
| Price To Earning | (23.89) X | |||
| Price To Book | 2.23 X | |||
| Price To Sales | 27.78 X | |||
| Revenue | 168.94 M | |||
| EBITDA | (42.3 M) | |||
| Cash And Equivalents | 836.06 M | |||
| Cash Per Share | 5.11 X | |||
| Total Debt | 22.86 M | |||
| Debt To Equity | 1.10 % | |||
| Book Value Per Share | 9.66 X | |||
| Cash Flow From Operations | (68.24 M) | |||
| Earnings Per Share | (0.41) X | |||
| Total Asset | 2.47 B | |||
| Retained Earnings | (138 M) | |||
| Current Asset | 1.51 B | |||
| Current Liabilities | 44 M | |||
About Phytohealth Corp Performance
Evaluating Phytohealth Corp's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Phytohealth Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Phytohealth Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
PhytoHealth Corporation engages in the development of botanical drugs in Asia. PhytoHealth Corporation is a subsidiary of Maywufa Company Ltd. PHYTOHEALTH CORP operates under Drug Manufacturers - Major classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Phytohealth Corp performance evaluation
Checking the ongoing alerts about Phytohealth Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Phytohealth Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 168.94 M. Net Loss for the year was (77.72 M) with profit before overhead, payroll, taxes, and interest of 78.31 M. | |
| Phytohealth Corp has accumulated about 836.06 M in cash with (68.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11. | |
| Roughly 24.0% of the company shares are owned by insiders or employees |
- Analyzing Phytohealth Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Phytohealth Corp's stock is overvalued or undervalued compared to its peers.
- Examining Phytohealth Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Phytohealth Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Phytohealth Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Phytohealth Corp's stock. These opinions can provide insight into Phytohealth Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Phytohealth Stock Analysis
When running Phytohealth Corp's price analysis, check to measure Phytohealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phytohealth Corp is operating at the current time. Most of Phytohealth Corp's value examination focuses on studying past and present price action to predict the probability of Phytohealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phytohealth Corp's price. Additionally, you may evaluate how the addition of Phytohealth Corp to your portfolios can decrease your overall portfolio volatility.